Subscribe for perks & to support LI

Your Interests & Preferences: Personalise your reading

Which best describes your role and/or interests?

I work in a law firm
I work for a company / in-house
I'm a litigator at the bar
I'm a law student
Aspiring law student
Save setting
Or click here to show more preferences...

I am interested in the following types of stories (uncheck to hide from frontpage)

Firms / In-House
Legal Education

Always show me: (overrides the above)

Exclusives & Editor's Picks

Website Look & Feel

Light Text on Dark Background

Save preferences

Note: Your preferences will be saved in your browser. You can always change your settings by clicking the Your Preferences button at the top of every page.

Reset preferences to defaults?

SAM, CAM on TPG buy in Sai Lifesciences

“American private equity firm TPG has acquired a significant minority stake in Sai Life Sciences, a drug discovery, development and manufacturing service provider,” reported Mint.

Shardul Amarchand Mangaldas managing partner Akshay Chudasama, principal associate Sayak Maity and senior associate Ankit Mishra acted for TPG with due diligence assistance from senior associate Aditi Tralshawala and associates Payal Chhabria and Neha Shaw.

Cyril Amarchand Mangaldas acted for Sai Lifesciences, led by Bangalore-based partners Arjun Lall and Nagavalli G.

Update 2 August 2018: PDS Legal acted for existing investor HBM Private Equity in relation to the transaction documentation, led by partner Vihang Virkar and director Ayesha Rai.

Click to show 13 comments
at your own risk
By reading the comments you agree that they are the (often anonymous) personal views and opinions of readers, which may be biased and unreliable, and for which Legally India therefore has no liability. If you believe a comment is inappropriate, please click 'Report to LI' below the comment and we will review it as soon as practicable.
refresh Filter out low-rated comments. Show all comments. Sort chronologically
Like +1 Object -0 Curious Outsider 01 Aug 18, 19:13
Do firms in India have pharma teams like they have in UK or US or do M&A lawyers do that.
Reply Report to LI
Like +0 Object -5 Yes 01 Aug 18, 22:30
Believe NDA is good at pharma, and also has a doctor as partner to focus on this area
Reply Report to LI
Like +1 Object -10 Ex Khaitan 01 Aug 18, 23:13
Khaitan has few rockstar partners who specialize in Pharma!!
Reply Report to LI
Like +4 Object -0 Ex Client 02 Aug 18, 16:03
Making photocopies of a single writ draft and filing for peanuts simply by changing the memo of parties and paras 1,2 and 3 does not make you a specialist in pharma. You need to understand the industry, keep on top of latest developments and moreover demonstrate more than textbook knowledge.
Reply Report to LI
Like +0 Object -1 Ok 02 Aug 18, 19:37
Why's a pharma client commenting on Legally India posts about Khaitan. Kaafi suspicious
Reply Report to LI
Like +1 Object -0 Badbad 02 Aug 18, 21:14
Maybe the writ was dismissed.
Reply Report to LI
Like +3 Object -0 Guest 02 Aug 18, 12:52
Lol doctor as a pharma expert!
Reply Report to LI
Like +0 Object -1 Kissan 02 Aug 18, 14:11
Indeed. I was expecting that the'll hire only farmers as pharma experts! Doctor doesn't make sense.
Reply Report to LI
Like +1 Object -0 Transl. scientist 02 Aug 18, 16:02
'Cause doctors know so much about dissociation constants and drug kinetics, right? Or the process of drug discovery from in silico processes to synthesis to animal to human trials?
Reply Report to LI
Like +8 Object -3 Helpful Insider 01 Aug 18, 19:42  interesting
Cyril Amarhand has dedicated lawyers who focus on Pharma, Life Sciences & Bio Tech etc. Happy to send you further details, if you like?
Reply Report to LI
Like +12 Object -7 Lol 02 Aug 18, 12:42  interesting  controversial
How is this not solicitation?
Reply Report to LI
Like +8 Object -3 BCI 02 Aug 18, 13:46  interesting
Sab ko andar karo!
Reply Report to LI
Like +2 Object -0 Observation 02 Aug 18, 20:15
A certain Khaitan partner had some good TPG work coming in, which ultimately went SAM's way. I wonder if this was picked up in his review.
Reply Report to LI

Latest comments